Monitor of New Drugs

The Monitor of New Drugs (MND) assesses the presence of new (mostly unregulated) psychoactive substances in the DIMS system, along with data from the National Forensic Institute and the Customs Laboratory.

The MND reports directly to the Ministry of Health, Welfare, and Sport, as well as to the Office of the Coordination, Assessment and Monitoring of New Drugs.